Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
132.6 SAR | +1.22% | +0.76% | +15.30% |
May. 09 | Tadawul Shares Plunge Thursday as Saudi Arabia’s March Industrial Output Falls | MT |
May. 09 | Jamjoom Pharmaceuticals Posts Higher Q1 Net Profit, Revenue | MT |
Sales 2024 * | 1.32B 352M | Sales 2025 * | 1.47B 392M | Capitalization | 9.28B 2.48B |
---|---|---|---|---|---|
Net income 2024 * | 366M 97.66M | Net income 2025 * | 402M 107M | EV / Sales 2024 * | 6.8 x |
Net cash position 2024 * | 318M 84.85M | Net cash position 2025 * | 485M 129M | EV / Sales 2025 * | 5.98 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
23.1
x | Employees | - |
Yield 2024 * |
2.37% | Yield 2025 * |
2.64% | Free-Float | 30% |
1 day | +1.22% | ||
1 week | +0.76% | ||
1 month | +2.16% | ||
3 months | -8.17% | ||
6 months | +16.32% | ||
Current year | +15.30% |
Managers | Title | Age | Since |
---|---|---|---|
Tarek Hosni
CEO | Chief Executive Officer | 60 | 21-05-14 |
Anwer Muhiddein
DFI | Director of Finance/CFO | 60 | 13-01-12 |
Mohammed Jamjoom
COO | Chief Operating Officer | 29 | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faris AlGhannam
BRD | Director/Board Member | - | 22-06-18 |
Chairman | 64 | 22-06-18 | |
Founder | 39 | 22-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 132.6 | +1.22% | 177,309 |
24-05-29 | 131 | -1.21% | 106,869 |
24-05-28 | 132.6 | -.--% | 113,106 |
24-05-27 | 132.6 | +1.22% | 92,804 |
24-05-26 | 131 | -0.46% | 36,298 |
Delayed Quote Saudi Arabian S.E., May 30, 2024 at 08:20 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.30% | 2.47B | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-0.05% | 6.79B | |
-9.58% | 6.8B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 4015 Stock